Login

Telling founders no Board meeting etiquette|Michael Luciani,Managing Partner,Climate Capital 00:10:00

Share On Facebook Share On Twitter

Managing Partner at Climate Capital.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Kamal Aggarwal on Chemcon Speciality's Future Growth Prospects | Kamal Aggarwal, Chairman, Chemcon Speciality Chemicals Ltd.
00:10:00
2019 Market Outlook with Owen Fitzpatrick, Portfolio Manager at Aristotle Atlantic Partners
00:10:00
Navigating Economic Challenges: N. Gregory Mankiw on Policy Tradeoffs for Shared Prosperity | Robert M. Beren Professor of Economics, Harvard University
00:10:00
Liberalism in Cold War Era: Evolving Ideals and Intellectual Debates|Samuel Moyn,Professor,Yale University
00:10:00
Exploración Minera en San Juan: Oportunidades y Desafíos
00:10:00
Meet Megan Geary: Syverson Strege Team Interview | Megan Geary - Accounting Assistant of Syverson Strege
00:10:00
"David Harden, CEO of Summit Global Investments, and Guy Lebas, chief fixed income strategist at Janney Montgomery Scott, discuss market insights with CNBC's Steve."
00:10:00
Accelerating Electric Vehicle Adoption: Challenges and Imperatives for New Zealand |Fraser Whineray, CEO, Mercury Nz Ltd.
00:10:00
ALT Smart City Chaiyaphum | Kent Sargent, CEO, ALT Telecom PCLALT:SET
00:10:00
Hyden Ross on Pathway's Three-Step Approach to Financial Planning | Hyden Ross, Director, Pathway Financial Planners.
00:10:00
StrikePoint Gold Gears Up for Drilling at Hercules Project in Nevada|Michael G. Allen,CEO,StrikePoint Gold Inc
00:10:00
Q3 Results Interview with CEO of Eastnine | Kestutis Sasnauskas, CEO, Eastnine AB.

© 2026 Nehu